Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Takeda Initiates Global Phase 3 Clinical Trial (TIDES) of Dengue Vaccine Candidate (TAK-003)

Thursday, September 08, 2016

Takeda Pharmaceutical Company Limited announced that it has vaccinated the first subject in the Tetravalent Immunization against Dengue Efficacy Study TIDES a Phase doubleblind randomized and placebocontrolled trial of its liveattenuated tetravalent...

Tonix to stop testing drug for fibromyalgia, shares plunge

Wednesday, September 07, 2016

Tonix Pharmaceuticals Holding Corp said it would stop developing its drug for fibromyalgia after the treatment failed in a latestage trial sending its shares down nearly percent The company said on Tuesday it would now focus on a latestage study of...

Allergan vows limited price hikes, says 'outliers' deter research

Wednesday, September 07, 2016

The chief executive officer of Allergan Plc said his company would limit annual price increases on its prescription drugs and that outlier drugmakers that have imposed huge price increases on their products were scaring off venture capital investors...

GSK's triple drug cuts flare-ups in chronic lung disease

Wednesday, September 07, 2016

An experimental threeinone inhaled drug from GlaxoSmithKline significantly cut flareups in patients with chronic lung disease in a clinical trial researchers said on Tuesday GSK is ahead of rivals AstraZeneca and Novartis in developing a closed trip...

Avara Acquires AstraZeneca UK Manufacturing Facility

Wednesday, September 07, 2016

Avara Pharmaceutical Services Inc announced that they have entered into an agreement under which Avara will acquire AstraZenecas manufacturing facility located in Avlon Avonmouth England Under the terms of the agreement about Avlon employees will r...

Alvogen Launches First Generic Equivalent of CopaxoneTM in Europe

Tuesday, September 06, 2016

Alvogen today announced the launch of RemurelTM glatiramer acetate the first generic equivalent of CopaxoneTM in Central and Eastern Europe The product will be marketed as a once daily subcutaneous mg prefilled syringe under the brand name RemurelTM...

OGD2 Pharma and Syndivia launch collaboration to develop an ADC targeting the O-acetyl-GD2 cancer antigen

Tuesday, September 06, 2016

OGD Pharma SAS a biotechnology company developing innovative anticancer therapies targeting the Oacetylated form of the GD ganglioside OAcGD today announces a collaboration with Syndivia SAS a biotechnology company that provides bestinclass bioconjug...

AstraZeneca seeks edge over rivals in severe asthma treatment

Tuesday, September 06, 2016

AstraZeneca hopes to convince doctors its experimental injection for severe asthma has an edge over two approved rivals after clinical trials data on Monday showed it worked well when given just once every two months The drugmaker has previously fla...

Galapagos gets orphan drug designation in EU for GLPG1690 in idiopathic pulmonary fibrosis

Tuesday, September 06, 2016

Galapagos announces today that the European Commission EC has granted GLPG orphan drug designation for the treatment of patients with idiopathic pulmonary fibrosis IPF IPF is a chronic progressive fibrotic disorder of the lungs that typically affect...

U.S. lawmakers question Mylan's Medicaid EpiPen rebates

Saturday, September 03, 2016

Two key US congressional committee members on Friday called for an investigation into whether Mylan NV under fire for raising the price of its EpiPen device overcharged the governments lowincome healthcare program for the allergy treatment In a lett...